TITLE

Hyperosmolar Versus Detergent Sclerosing Agents in Sclerotherapy

AUTHOR(S)
Sadick, Neil S.
PUB. DATE
May 1994
SOURCE
Journal of Dermatologic Surgery & Oncology;May94, Vol. 20 Issue 5, p313
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND. sclerosing agents produce local endothelial destruction extending to the adventitia of the vessel wall While producing minimal thrombosis formation. They are rapidly inactivated in order to prevent damage far beyond the injection site. It has been stated that detergent sclerosants may have more distal sclerosing capabilities than hyperosmolar sclerosants. OBJECTIVE. The present study compares the in vivo relative Potential of polidocanol (POL.), a detergent sclerosing agent, and hypertonic saline (H.S.), a hyperosmolar sclerosant in their effects on distal vessel obliteration. METHOD. Symmetrical Class III reticular vessels of 2-3-mm diameter were injected with equal amounts (0.5 cc) of sclerosing solutions: 0.5% POL in the left leg and 23.4% U.S. in the right leg. Distance of vessel sclerosing effect was Calibrated from the inferior patellar tendon employing a Calibrated measuring window. Standard compression (20- 30 mm Hg) was employed for 72 hours after each treatment Session. Patients were examined at 2-, 4-, 6-, 8-, 10-, and 16-week intervals for vascular sclerosing resolution effect. RESULTS. The mean distance of vessel sclerosis utilizing 23.4% H.S. was 6.24 cm vs 6.34 cm utilizing 0.5% POL. The mean duration of time to clinical disappearance of treated vessels was 6.4 weeks for the H.S.-treated extremity vs 6.2 weeks of the POL. -treated extremity. The difference of both parameters in terms of distance of sclerosing effect and time interval to achieve this effect were not statistically significant for either variable utilizing POL. or H.S.. CONCLUSIONS. Hyperosmolar and detergent sclerosants such as POL. and H.S. in comparable concentrations for given vessel diameter may provide equal degrees of vessel obliteration clinically over equivalent periods of time in vivo. Other factors such as minimal sclerosant concentration, hypersensitivity/complication profile, patient discomfort, sclerosant availability, and physician experience are other important factors in choosing a sclerosing agent for a given clinical setting.
ACCESSION #
12943300

 

Related Articles

  • Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin. He Hu; Xiao-xue Zhang; Yin-ye Wang; Shi-zhong Chen // Acta Pharmacologica Sinica;Sep2005, Vol. 26 Issue 9, p1063 

    To study the effect of honokiol on arterial thrombosis and endothelial cells. Rabbit platelet aggregation was performed with Born's turbid method. Thrombosis was produced by the endothelial injury stimulated with electric current. Rat aortic endothelial cells (RAEC) were cultured and cell...

  • Compression Stockings and Post-Thrombotic Syndrome. Shaughnessy, Allen F. // American Family Physician;1/1/2005, Vol. 71 Issue 1, p144 

    Deals with whether off-the-shelf compression stockings can prevent post-thrombotic syndrome in patients with a proximal deep venous thrombosis. Patients who were diagnosed with mild post-thrombotic syndrome in the study; List of post-thrombotic symptoms.

  • Experimental antithrombotic effect of potatoes harvested in the autumn. Yamamoto, Junichiro; Masuda, Megumi; Hyodo, Kanae; Iwasaki, Masahiro // Health (1949-4998);Feb2012, Vol. 4 Issue 2, p108 

    Prevention of arterial thrombotic diseases has a high priority in developed countries. While an inappropriate diet is known to enhance the risk for acute thrombotic events, a regular diet with proven antithrombotic effects might be beneficial in the prevention of such diseases. The present study...

  • Hereditary and Acquired Thrombophilic Disorders. Bick, Rodger L. // Clinical & Applied Thrombosis/Hemostasis;Apr2006, Vol. 12 Issue 2, p125 

    Presents research which assessed hereditary and acquired thrombophilic disorders. Percentage of deaths in the U.S. caused by thrombosis; Influence of hemorrhage on the development of dysfibrinogenemia; Association of hyperhomocystinemia with arterial and venous thrombosis; Impact of heparin...

  • The ABCs of DVT. Sprizza, Lori; Witko, Audrey // MEDSURG Nursing;Dec2003, Vol. 12 Issue 6, p403 

    Provides information on deep vein thrombosis (DVT). Factors that initiate the clotting process in the blood and increase the likelihood of clot formation; Clinical symptoms and signs of DVT; Nursing implications.

  • Molecular Diagnostics of Inherited Thrombosis. League, Stacy; Hooper, W. Craig // Clinical Laboratory Science;Fall2005, Vol. 18 Issue 4, p271 

    Thrombophilia can best be defined as a disorder of coagulation that contributes to a predisposition towards thrombosis. Although the term thrombophilia has been used to describe arterial thrombosis, its most common usage has been in reference to venous thromboembolism (VTE). Thrombophilia can be...

  • Deep vein thrombosis. Watkins, Jean // Practice Nursing;Aug2009, Vol. 20 Issue 8, p409 

    The article offers information on the common symptoms of deep vein thrombosis (DVT). A study found that over 70% of patients with clinically suspected DVT are found to have some other cause for their symptoms. Deaths associated with such conditions are related to the complication of a pulmonary...

  • Commentary. Stevens, Scott M.; Ageno, Walter // Evidence Based Medicine;Apr2006, Vol. 11 Issue 2, p56 

    The article presents a comment on the study on the detection of presence or absence of deep vein thrombosis by using individual clinical features, structured risk scores and physicians' empirical judgments. DVT has non-specific clinical presentation. D-dimer, a breakdown product of fibrin, is...

  • Massive hemoptysis and deep venous thrombosis presenting in a woman with Hughes-Stovin syndrome: a case report. Al-Jahdali, Hamdan // Journal of Medical Case Reports;2010, Vol. 4 Issue 1, p1 

    Introduction: Hughes-Stovin syndrome is a very rare disease with fewer than 30 cases reported in the literature. The disease is thought to be a variant of Behcet's disease and is defined by the presence of pulmonary artery aneurysm in association with peripheral venous thrombosis. Case...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics